A LinkedIn post from HOPPR highlights the hiring of Sara Ranjbar, Ph.D., as a Data Scientist with a focus on medical imaging AI and scalable data pipelines for clinical systems. The post notes her experience in computer vision model development, clinical validation, and integration of AI tools into healthcare workflows.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to the post, Ranjbar’s prior work at MD Anderson Cancer Center included contributing to AI models for pathology and advancing a breast cancer immune scoring system toward simulated clinical deployment, in coordination with regulatory and clinical teams. She also completed postdoctoral training at Mayo Clinic, where she developed deep learning and radiomics models across multiple imaging modalities and received the Edward C. Kendall Award for Meritorious Research.
The post suggests that her role at HOPPR will involve advancing the company’s approach to imaging AI development, potentially strengthening its capabilities in clinically oriented, validated AI solutions. For investors, this hire may indicate ongoing investment in specialized talent aimed at enhancing product robustness, regulatory readiness, and real-world adoption prospects in the healthcare AI segment.

